MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
MOUNT LAUREL, N.J.,Nov. 20 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ) and Primordial Inc., a leading provider of communication, workflow and analytics applications for radiology, today announced a cooperative agreement to integrate four Primordial modules with MedQuist's top-ranked interactive front-end speech recognition solution, SpeechQ for Radiology(TM). The companies will be demonstrating these solutions in MedQuist's booth (#7113) at RSNA 2008 (Nov. 30-Dec. 4 in Chicago):
Primordial Flow, an integrated and contextual communication and collaboration application for radiologists using SpeechQ. The application includes communication and management of critical results in a JCAHO-compliant manner.
Primordial Metrix, a real-time digital dashboard of key performance and efficiency indicators as well as powerful ad hoc reports generated from SpeechQ data. This will be facilitated through HL7 messages monitored by Primordial.
Primordial Problem Detect, an application that proactively detects key radiology workflow problems such as stuck exams, late reports, missing reports, images that arrive after an exam has been dictated, and more.
Primordial Search, a"Google(TM)-like" unstructured, browser-based search application that finds patients, orders, and diagnostic reports. Even with complex queries, results are returned in under a second.
The integration of these products provides a seamless user experience, with single sign-on, and synchronized patient and exam context between Primordial applications and SpeechQ. This approach is similar to the integration of Primordial solutions with PACS that Primordial Inc. provides today to more than 80 customers.
"We are extremely pleased to partner with MedQuist and integrate our unique and innovative solutions with what we believe is the strongest Radiology speech recognition solution on the market today -- SpeechQ. The market is increasingly demanding tight integrations of best-of-breed applications, and that is what we hope to provide," comments Philip Zarboulas, Primordial principal and director of business development.
Chris Spring, MedQuist director of speech recognition solutions, adds, "SpeechQ users should see numerous benefits from the interoperability of our solution with partners such as Primordial. For example, providing a user with the ability to report critical or urgent results through an integrated system reduces the number of 'clicks' or times a radiologist needs to make an action. We are making SpeechQ work in new and exciting ways."
About Primordial
Primordial Inc. offers solutions that address radiology departments' critical communications, monitoring, and analytics needs, including:
Communication and documentation of critical results
Tracking of critical test lifecycles
Exam turnaround time calculation and analysis
Workflow backlogs
Problem detection.
These solutions integrate with RIS, PACS and SpeechQ, and are customized to support each facility's specific workflows.
About MedQuist
MedQuist is the largest Medical Transcription Service Organization (MTSO) in the world, and a leader in technology-enabledclinical documentation workflow. MedQuist's enterprisesolutions - including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors - help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation the risk that SpeechQ for Radiology does not perform as designed. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.